Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
10 Apr 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2023 Download
21 Feb 2023 Annual Corporate Governance Report ROVI releases the 2022 Annual Corporate Governance Report Download
21 Feb 2023 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors Download
16 Feb 2023 On business and financial situation The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. Download
09 Jan 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the fourth quarter of 2022 Download

Pages

Date Title Description PDF
06 Nov 2018 Información sobre resultados ROVI releases the presentation related to the nine-month period ended 30 September 2018 results. Download
06 Nov 2018 Información sobre resultados ROVI releases the press release related to the nine-month period ended 30 September 2018 results. Download
17 Oct 2018 Buy-back programmes, stabilisation and treasury stock ROVI informs of the resumption of operations with own shares under the liquidity contract Download
17 Oct 2018 Buy-back programmes, stabilisation and treasury stock ROVI informs that Jefferies International Limited has exercised, in full, the greenshoe subscription option Download
08 Oct 2018 Share capital increases and reductions Information on new shares admissions related to the capital increase of ROVI Download

Pages